AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DEXAMETHASONE + NEOMYCIN

11 registrations across 5 African markets— 10 active

Markets with DEXAMETHASONE + NEOMYCIN

Recent registrations

Brand / ProductMarketHolderStatusExpires
Neomdexsol Eye Drops
Eye drops
🇳🇬NigeriaExpharlab LimitedactiveJul 2028
NEODEXONE
OINTMENT; OPHTHALMIC
🇿🇼ZimbabweCAPS PVT LTDactiveDec 2027
Dexoptic-N Eye Drops
Solution/Drops
🇳🇬NigeriaLin-Kabs Pharmaceutical LimitedactiveSept 2026
WW_NEODEX 0.1% & 3.5% EYE DROPS
EYE DROPS
🇲🇼MalawiexpiredMar 2025
XSONE N
Ear/Eye Drops
🇹🇿TanzaniaAbacus Parenteral Drugs Ltd (APDL)active
Dextracin
Solution
🇹🇿TanzaniaXepa-Soul Pattinson (Malaysia)active
DEXAMETHASONE + NEOMYCIN
OPHTHALMIC DROPS
🇺🇬UgandaXEPA SOUL PATTISON (M) SDN BHDactive
Ivydexneocin Eye/Ear Drops
Ear/Eye Drops
🇹🇿TanzaniaB. Braun Pharmaceuticals EPZ Ltdactive
DEXAMETHASONE + NEOMYCIN
OPHTHALMIC DROPS
🇺🇬UgandaXEPA SOUL PATTISON (M) SDN BHDactive
Pharmadexneocin
Drops
🇹🇿TanzaniaIVEE AQUA EPZ Limitedactive
Dexwin
Eye Drops
🇹🇿TanzaniaNabiQasim industries Pvt Ltdactive

DEXAMETHASONE + NEOMYCIN in Africa — Regulatory Overview

DEXAMETHASONE + NEOMYCIN is registered across 5 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Nigeria, Uganda, Malawi and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 10 (91%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.